AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8681669 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose fenoterol (5 mg)
Number of subjects: 24
Study 8681669 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose fenoterol (1 mg)
Number of subjects: 24
Study 8681669 — intervention group
Group type: COMPARATOR
Intervention: Ipratropium bromide (0.5 mg)
Number of subjects: 24
Study 8681669 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 1736585 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonpharmacologic therapy
Number of subjects: 79
Study 1736585 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 79
Study 1736585 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study 6143849 — intervention group
Group type: EXPERIMENTAL
Intervention: Corgard (nadolol) 80 mg
Number of subjects: 17
Study 6143849 — intervention group
Group type: COMPARATOR
Intervention: Propranolol (control)
Number of subjects: 17
Study 6143849 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 17
Study 6143849 — intervention group
Group type: COMPARATOR
Intervention: Obsidian (control)
Number of subjects: 17
Study 30723876 — intervention group
Group type: EXPERIMENTAL
Intervention: Plazomicin
Number of subjects: 0
Study 30723876 — intervention group
Group type: EXPERIMENTAL
Intervention: Plazomicin-based combinations
Number of subjects: 0
Study 29943207 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT) + conventional exercise (TG)
Number of subjects: 32
Study 29943207 — intervention group
Group type: COMPARATOR
Intervention: Conventional exercise (CG)
Number of subjects: 32
Study 27036991 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir alafenamide (200 mg emtricitabine with 10 mg or 25 mg tenofovir alafenamide)
Number of subjects: 668
Study 27036991 — intervention group
Group type: COMPARATOR
Intervention: Tenofovir disoproxil fumarate (200 mg emtricitabine with 200 mg or 300 mg tenofovir disoproxil fumarate)
Number of subjects: 668
Study 27036991 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir alafenamide
Number of subjects: 668
Study 27036991 — intervention group
Group type: COMPARATOR
Intervention: Tenofovir disoproxil fumarate
Number of subjects: 668
Study 27036991 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 668
Study 24513620 — intervention group
Group type: EXPERIMENTAL
Intervention: Throwing-specific exercise (THROW)
Number of subjects: 13
Study 24513620 — intervention group
Group type: COMPARATOR
Intervention: General exercise (RUN)
Number of subjects: 13
Study 22931176 — intervention group
Group type: EXPERIMENTAL
Intervention: Texting (N = 45)
Number of subjects: 186
Study 22931176 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating (N = 45)
Number of subjects: 186
Study 22931176 — intervention group
Group type: COMPARATOR
Intervention: Control (N = 96)
Number of subjects: 186
Study 20192914 — intervention group
Group type: EXPERIMENTAL
Intervention: Chromium picolinate (1000 microg daily)
Number of subjects: 80
Study 20192914 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 17011699 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacropexy combined with Burch colposuspension (Group A)
Number of subjects: 66
Study 17011699 — intervention group
Group type: COMPARATOR
Intervention: No anti-incontinence procedure (Group B)
Number of subjects: 66
Study 16281925 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuropathy symptom score
Number of subjects: 142
Study 16281925 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuropathy sign score
Number of subjects: 142
Study 16281925 — intervention group
Group type: EXPERIMENTAL
Intervention: Michigan Neuropathy Disability Score (MNDS)
Number of subjects: 142
Study 16281925 — intervention group
Group type: EXPERIMENTAL
Intervention: Monofilament examination
Number of subjects: 142
Study 12071996 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% lidocaine and 0.5% phenylephrine ('co‐phenylcaine')
Number of subjects: 74
Study 12071996 — intervention group
Group type: COMPARATOR
Intervention: 10% cocaine spray
Number of subjects: 74
Study 9854437 — intervention group
Group type: EXPERIMENTAL
Intervention: Reinforcement based on voice loudness
Number of subjects: 0
Study 9854437 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no specific details provided)
Number of subjects: 0
Study 7611550 — intervention group
Group type: EXPERIMENTAL
Intervention: Primaquine (0.5 mg/kg every other day for 16-19 weeks)
Number of subjects: 99
Study 7611550 — intervention group
Group type: COMPARATOR
Intervention: Chloroquine (5 mg/kg weekly for 16-19 weeks)
Number of subjects: 99
Study 2227128 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporin therapy
Number of subjects: 98
Study 325009 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine sulphate
Number of subjects: 50
Study 325009 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 30782399 — intervention group
Group type: EXPERIMENTAL
Intervention: Cotton ball packing
Number of subjects: 39
Study 30782399 — intervention group
Group type: COMPARATOR
Intervention: No packing (control)
Number of subjects: 39
Study 27541076 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise-based cardiac rehabilitation (ECR) for 1 year
Number of subjects: 204
Study 27541076 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 204
Study 24961647 — intervention group
Group type: EXPERIMENTAL
Intervention: Tension-free vaginal tape (TVT)
Number of subjects: 201
Study 24961647 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous fascial sling (AFS)
Number of subjects: 201
Study 24961647 — intervention group
Group type: EXPERIMENTAL
Intervention: Xenograft sling (Pelvicol)
Number of subjects: 201
Study 24961647 — intervention group
Group type: COMPARATOR
Intervention: Comparison of AFS vs Pelvicol
Number of subjects: 201
Study 24961647 — intervention group
Group type: COMPARATOR
Intervention: Comparison of AFS vs TVT
Number of subjects: 201
Study 23243247 — intervention group
Group type: EXPERIMENTAL
Intervention: Phytase at normal usage levels (500 phytase units per kg of feed)
Number of subjects: 540
Study 23243247 — intervention group
Group type: EXPERIMENTAL
Intervention: Phytase at 2X and 3X levels
Number of subjects: 540
Study 23243247 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrase mixture
Number of subjects: 540
Study 23243247 — intervention group
Group type: EXPERIMENTAL
Intervention: Phytase (1X, 2X, 3X)
Number of subjects: 540
Study 21717823 — intervention group
Group type: EXPERIMENTAL
Intervention: Program B (modified elimination diet and phytonutrient-rich medical food)
Number of subjects: 8
Study 21717823 — intervention group
Group type: EXPERIMENTAL
Intervention: Program B
Number of subjects: 8
Study 21717823 — intervention group
Group type: COMPARATOR
Intervention: Program A (modified US Department of Agriculture food pyramid diet and rice protein powder supplement)
Number of subjects: 8
Study 19290537 — intervention group
Group type: EXPERIMENTAL
Intervention: EGCG
Number of subjects: 36
Study 19290537 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 16875850 — intervention group
Group type: EXPERIMENTAL
Intervention: Duplex ultrasound scanning (DUSS)
Number of subjects: 310
Study 16875850 — intervention group
Group type: COMPARATOR
Intervention: CT scanning
Number of subjects: 310
Study 12621482 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy plus stem-cell transplantation
Number of subjects: 180
Study 12621482 — intervention group
Group type: COMPARATOR
Intervention: Conventional-dose chemotherapy
Number of subjects: 180
Study 11049776 — intervention group
Group type: EXPERIMENTAL
Intervention: Home sampling
Number of subjects: 1700
Study 11049776 — intervention group
Group type: COMPARATOR
Intervention: Conventional swab sampling
Number of subjects: 1700
Study 9126306 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron alone (40 micrograms/kg)
Number of subjects: 34
Study 9126306 — intervention group
Group type: COMPARATOR
Intervention: Granisetron, methylprednisolone (250 mg/body), and droperidol (0.5 ml/body)
Number of subjects: 34
Study 8471555 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential methotrexate (250 mg/m2) and 5-fluorouracil (500 mg/m2) followed by leucovorin (15 mg x 8) (MFL)
Number of subjects: 202
Study 8471555 — intervention group
Group type: COMPARATOR
Intervention: Sequential 5-fluorouracil (500 mg/m2) followed by leucovorin (60 mg/m2) (FLv)
Number of subjects: 202
Study 2956392 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mmol sodium/day
Number of subjects: 16
Study 2956392 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mmol sodium/day (plus frusemide, 40 mg on day 1)
Number of subjects: 16
Study 2956392 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mmol sodium/day
Number of subjects: 16
Study 2956392 — intervention group
Group type: EXPERIMENTAL
Intervention: 120 mmol sodium/day
Number of subjects: 16
Study 2956392 — intervention group
Group type: EXPERIMENTAL
Intervention: Both diet phases (200 mmol and 15 mmol sodium/day)
Number of subjects: 16
Study 30760250 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive remediation intervention delivered in 12 one-hour group-based sessions over six weeks.
Number of subjects: 0
Study 30760250 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive remediation intervention
Number of subjects: 0
Study 30267987 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel (100 mg/m2)
Number of subjects: 762
Study 30267987 — intervention group
Group type: EXPERIMENTAL
Intervention: Ixabepilone (40 mg/m2)
Number of subjects: 762
Study 26416127 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailed interactive DVD
Number of subjects: 244
Study 26416127 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-tailored telephone counseling
Number of subjects: 244
Study 26416127 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 244
Study 24491807 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-1 (no history of otitis media)
Number of subjects: 33
Study 24491807 — intervention group
Group type: COMPARATOR
Intervention: Group-2 (history of otitis media)
Number of subjects: 33
Study 22861198 — intervention group
Group type: EXPERIMENTAL
Intervention: Water aerosol of an alpine waterfall for 1 hour per day
Number of subjects: 54
Study 22861198 — intervention group
Group type: COMPARATOR
Intervention: Control site for 1 hour per day
Number of subjects: 54
Study 21029895 — intervention group
Group type: EXPERIMENTAL
Intervention: +3.00 D IOL
Number of subjects: 32
Study 21029895 — intervention group
Group type: COMPARATOR
Intervention: +4.00 D IOL
Number of subjects: 32
Study 18940491 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial forearm flap
Number of subjects: 20
Study 18940491 — intervention group
Group type: COMPARATOR
Intervention: Anterolateral thigh flap
Number of subjects: 20
Study 15913717 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal measurement of intra-abdominal pressure (Pvag)
Number of subjects: 100
Study 15913717 — intervention group
Group type: COMPARATOR
Intervention: Rectal measurement of intra-abdominal pressure (Prec)
Number of subjects: 100
Study 15913717 — intervention group
Group type: EXPERIMENTAL
Intervention: Both methods (Pvag and Prec)
Number of subjects: 100
Study 12111492 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane anesthesia
Number of subjects: 12
Study 12111492 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol anesthesia
Number of subjects: 12
Study 10198865 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooled intraocular irrigating solution (approximately 10 degrees C)
Number of subjects: 40
Study 10198865 — intervention group
Group type: COMPARATOR
Intervention: Room temperature irrigating solution
Number of subjects: 40
Study 8579349 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative progress reports (5-10 minutes)
Number of subjects: 150
Study 8579349 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control group)
Number of subjects: 150
Study 8579349 — intervention group
Group type: COMPARATOR
Intervention: Attention protocol (Attention group)
Number of subjects: 150
Study 2180471 — intervention group
Group type: COMPARATOR
Intervention: melphalan-prednisone (MP)
Number of subjects: 164
Study 2180471 — intervention group
Group type: EXPERIMENTAL
Intervention: multidrug chemotherapy (MDC)
Number of subjects: 164
Study 7437260 — intervention group
Group type: EXPERIMENTAL
Intervention: Herbal cigarette
Number of subjects: 6
Study 7437260 — intervention group
Group type: COMPARATOR
Intervention: Tobacco cigarette
Number of subjects: 6
Study 31687751 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported physical activity (IPAQ-short)
Number of subjects: 235
Study 31123069 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-sodium peritoneal dialysis fluid (125 mmol/L Na)
Number of subjects: 82
Study 31123069 — intervention group
Group type: COMPARATOR
Intervention: Standard-sodium peritoneal dialysis fluid (134 mmol/L Na)
Number of subjects: 82
Study 28104097 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% NaHCO3 and distilled water solution at 40-45°C
Number of subjects: 143
Study 28104097 — intervention group
Group type: COMPARATOR
Intervention: 75% alcohol
Number of subjects: 143
Study 25882712 — intervention group
Group type: EXPERIMENTAL
Intervention: TTM between 32.5 and 33.5°C (therapeutic hypothermia)
Number of subjects: 584
Study 25882712 — intervention group
Group type: COMPARATOR
Intervention: TTM between 36.5 and 37.5°C (therapeutic normothermia)
Number of subjects: 584
Study 24066023 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard magnetic wrist strap (1502 to 2365 gauss)
Number of subjects: 70
Study 24066023 — intervention group
Group type: EXPERIMENTAL
Intervention: Demagnetised wrist strap (<20 gauss)
Number of subjects: 70
Study 24066023 — intervention group
Group type: EXPERIMENTAL
Intervention: Attenuated magnetic wrist strap (250 to 350 gauss)
Number of subjects: 70
Study 24066023 — intervention group
Group type: EXPERIMENTAL
Intervention: Copper bracelet
Number of subjects: 70
Study 24066023 — intervention group
Group type: COMPARATOR
Intervention: Placebo (demagnetised wrist strap)
Number of subjects: 70
Study 21841287 — intervention group
Group type: EXPERIMENTAL
Intervention: I Can Cope cancer education program
Number of subjects: 140
Study 19236457 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous immunoglobulin (SCIG)
Number of subjects: 9
Study 19236457 — intervention group
Group type: COMPARATOR
Intervention: Intravenous immunoglobulin (IVIG)
Number of subjects: 9
Study 17177056 — intervention group
Group type: EXPERIMENTAL
Intervention: Albendazole (15 mg/kg/day for 2 weeks)
Number of subjects: 66
Study 17177056 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 17177056 — intervention group
Group type: EXPERIMENTAL
Intervention: Albendazole
Number of subjects: 66
Study 15109505 — intervention group
Group type: EXPERIMENTAL
Intervention: High frequency, low intensity TENS (HFT)
Number of subjects: 180
Study 15109505 — intervention group
Group type: EXPERIMENTAL
Intervention: High frequency, high intensity TENS (HIT)
Number of subjects: 180
Study 15109505 — intervention group
Group type: COMPARATOR
Intervention: Control TENS (COT)
Number of subjects: 180
Study 11692055 — intervention group
Group type: EXPERIMENTAL
Intervention: PPI plus clarithromycin plus amoxycillin for 7 days
Number of subjects: 481
Study 11692055 — intervention group
Group type: EXPERIMENTAL
Intervention: RBC plus clarithromycin plus amoxycillin for 7 days
Number of subjects: 481
Study 11692055 — intervention group
Group type: EXPERIMENTAL
Intervention: RBC plus clarithromycin plus amoxycillin plus metronidazole for 5 days
Number of subjects: 481
Study 11692055 — intervention group
Group type: COMPARATOR
Intervention: Overall eradication in NUD patients
Number of subjects: 481
Study 11692055 — intervention group
Group type: COMPARATOR
Intervention: Overall eradication in PUD patients
Number of subjects: 481
Study 11692055 — intervention group
Group type: EXPERIMENTAL
Intervention: RBC plus clarithromycin plus amoxycillin for 7 days in NUD
Number of subjects: 481
Study 9146316 — intervention group
Group type: EXPERIMENTAL
Intervention: Autotransfusion of shed mediastinal blood for 18 hours
Number of subjects: 135
Study 9146316 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 135
Study 7939142 — intervention group
Group type: EXPERIMENTAL
Intervention: Allergic children
Number of subjects: 121
Study 7939142 — intervention group
Group type: EXPERIMENTAL
Intervention: Allergic adults
Number of subjects: 121
Study 7939142 — intervention group
Group type: COMPARATOR
Intervention: Non-allergic children
Number of subjects: 121
Study 7939142 — intervention group
Group type: COMPARATOR
Intervention: Non-allergic adults
Number of subjects: 121
Study 3070049 — intervention group
Group type: EXPERIMENTAL
Intervention: 250mg of caffeine
Number of subjects: 36
Study 3070049 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 31397204 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative enema (n=114)
Number of subjects: 225
Study 31397204 — intervention group
Group type: COMPARATOR
Intervention: No preoperative enema (n=111)
Number of subjects: 225
Study 30816573 — intervention group
Group type: EXPERIMENTAL
Intervention: miR-497-5p overexpression
Number of subjects: 2
Study 30816573 — intervention group
Group type: COMPARATOR
Intervention: miR-497-5p inhibition
Number of subjects: 2
Study 30816573 — intervention group
Group type: COMPARATOR
Intervention: SOX5 overexpression
Number of subjects: 2
Study 30261083 — intervention group
Group type: EXPERIMENTAL
Intervention: Care-seeking from trained providers
Number of subjects: 2868
Study 27091825 — intervention group
Group type: EXPERIMENTAL
Intervention: Supported communication for aphasia training
Number of subjects: 20
Study 27091825 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 20
Study 24661836 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole grain rye crisp bread (RB)
Number of subjects: 41
Study 24661836 — intervention group
Group type: COMPARATOR
Intervention: Refined wheat bread (WB)
Number of subjects: 41
Study 22185963 — intervention group
Group type: EXPERIMENTAL
Intervention: HX575 (subcutaneous administration)
Number of subjects: 337
Study 22185963 — intervention group
Group type: COMPARATOR
Intervention: Erypo®/Eprex® (control group)
Number of subjects: 337
Study 20685806 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation with walking visual illusion
Number of subjects: 39
Study 20685806 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation
Number of subjects: 39
Study 20685806 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual illusion
Number of subjects: 39
Study 20685806 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation with visual illusion
Number of subjects: 39
Study 20685806 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation with control illusion
Number of subjects: 39
Study 20685806 — intervention group
Group type: COMPARATOR
Intervention: Transcranial direct current stimulation with control illusion
Number of subjects: 39
Study 20685806 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment (transcranial direct current stimulation and visual illusion)
Number of subjects: 39
Study 18204328 — intervention group
Group type: EXPERIMENTAL
Intervention: Antithrombin (AT) supplementation
Number of subjects: 27
Study 18204328 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion of AT
Number of subjects: 27
Study 18204328 — intervention group
Group type: COMPARATOR
Intervention: Bolus method of AT supplementation
Number of subjects: 27
Study 15791603 — intervention group
Group type: EXPERIMENTAL
Intervention: Interview-assisted standardized questionnaire
Number of subjects: 114
Study 15791603 — intervention group
Group type: COMPARATOR
Intervention: Self-completed standardized questionnaire
Number of subjects: 114
Study 15791603 — intervention group
Group type: EXPERIMENTAL
Intervention: Interview-assisted questions
Number of subjects: 114
Study 15791603 — intervention group
Group type: COMPARATOR
Intervention: Self-completion
Number of subjects: 114
Study 12038935 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 1 e‐journals (completely electronic with no print counterpart)
Number of subjects: 45
Study 12038935 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 2 e‐journals (print and electronic versions with unique content)
Number of subjects: 45
Study 12038935 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 3 e‐journals (print and electronic versions containing equal content)
Number of subjects: 45
Study 12038935 — intervention group
Group type: COMPARATOR
Intervention: All types of e‐journals
Number of subjects: 45
Study 10887868 — intervention group
Group type: EXPERIMENTAL
Intervention: Certification program for nurses
Number of subjects: 193
Study 10887868 — intervention group
Group type: COMPARATOR
Intervention: Visual glucose oxidase strip (Chemstrip) procedure
Number of subjects: 193
Study 7737266 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg/day for at least 1 year
Number of subjects: 59
Study 7737266 — intervention group
Group type: COMPARATOR
Intervention: No treatment (lipid-lowering diet only)
Number of subjects: 59
Study 7737266 — intervention group
Group type: COMPARATOR
Intervention: Healthy male volunteers (normocholesterolaemic controls)
Number of subjects: 59
Study 2405735 — intervention group
Group type: EXPERIMENTAL
Intervention: pH-adjusted bupivacaine with hyaluronidase 15 units/ml (pH 6.82 +/‐ 0.09)
Number of subjects: 35
Study 2405735 — intervention group
Group type: COMPARATOR
Intervention: Plain bupivacaine with hyaluronidase (pH 5.45 +/‐ 0.12)
Number of subjects: 35
Study 2405735 — intervention group
Group type: COMPARATOR
Intervention: Control group (plain bupivacaine)
Number of subjects: 35
Study 2405735 — intervention group
Group type: EXPERIMENTAL
Intervention: pH-adjusted bupivacaine
Number of subjects: 35
Study 6107766 — intervention group
Group type: EXPERIMENTAL
Intervention: Mestranol (mean 23 x 3 micrograms/day)
Number of subjects: 100
Study 6107766 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 31501092 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal start dialysis group (DIFE value between 30 and 35)
Number of subjects: 388
Study 31501092 — intervention group
Group type: COMPARATOR
Intervention: Late-start dialysis group (DIFE value less than 30)
Number of subjects: 388
Study 31501092 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal start dialysis group
Number of subjects: 388
Study 31501092 — intervention group
Group type: COMPARATOR
Intervention: Late-start dialysis group
Number of subjects: 388